Find clinical trials for Lymphoma in Philadelphia, PA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near Philadelphia, PA, USA:
DS-3201b is an experimental drug that is being investigated in clinical research.Adults with non-Hodgkin lymphoma (NHL) may be able to join ...
Phase 1
Philadelphia, Pennsylvania, United States and 20 other locations
chimeric antigen receptor (CAR) targeting cluster of differentiation (CD)19 and CD20 in participants with aggressive large B-cell lymphoma....
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 34 other locations
of TLN-121 as a single agent and in combination with other anti-lymphoma therapies in patients with relapsed or refractory Non-Hodgkin Lymphomas...
Phase 1
Philadelphia, Pennsylvania, United States and 13 other locations
TrAVeRse is a multicentre, open-label, Phase II study of AVR in treatment naïve MCL participants. The primary objective will be to assess the rate of...
Phase 2
Philadelphia, Pennsylvania, United States and 28 other locations
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...
Phase 2
Allentown, Pennsylvania, United States and 71 other locations
in treating adults with relapsed/refractory (R/R) mantle cell lymphoma (MCL). This study will also look at the safety of sonrotoclax plus za...
Phase 3
West Reading, Pennsylvania, United States and 146 other locations
The primary objective of this study is to characterize the safety and tolerability of loncastuximab tesirine in combination with polatuzumab vedotin,...
Phase 1
Philadelphia, Pennsylvania, United States and 39 other locations
This study will characterize the safety and clinical benefit of valemetostat tosylate in participants with relapsed/refractory peripheral T-cell lymphoma...
Phase 2
Philadelphia, Pennsylvania, United States and 60 other locations
maraleucel (Breyanzi/liso-cel/BMS-986387) in adults as first-line treatment in transplant-ineligible Primary Central Nervous System Lymphoma...
Phase 2
Philadelphia, Pennsylvania, United States and 39 other locations
of DZR123 (Tulmimetostat, CPI-0209), both as monotherapy and in combination with enzalutamide, in patients with advanced solid tumors and lymphomas...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 79 other locations
Clinical trials
Research sites
Resources
Legal